Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Cardinal Health (CAH)

Cardinal Health adds Robert Musslewhite and Sudhakar Ramakrishna to board

Neutral Impact 2 of 5 leadership Written later

Cardinal Health's Board elected two new independent directors, Robert Musslewhite and Sudhakar Ramakrishna, effective March 7, 2025. The filing describes the appointments as board additions and does not mention any change in executive roles or financial results, so the direct effect on shareholders appears limited.

Key points

  • Board elected Robert Musslewhite and Sudhakar Ramakrishna effective March 7, 2025; both will serve until the 2025 annual meeting.
  • Musslewhite, former CEO of Definitive Healthcare Corp., joins the Audit and Human Resources and Compensation Committees.
  • Ramakrishna, President and CEO of SolarWinds Corporation, joins the Audit and Risk Oversight Committees.
  • The Board determined both directors are independent under New York Stock Exchange rules; their pay matches other non-employee directors.

The filing

CompanyCardinal Health (CAH)
Form8-K, current report
Filed with the SECMar 10, 2025, 6:53 AM ET
Accession number0000721371-25-000020

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 10, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.